10th European Medical Information and Communications Conference and Exhibition

29 - 30 November 2016, Berlin, Germany
The 10th year of the Annual European Medical Information and Communications Conference is a unique meeting organised by medical information professionals for medical information professionals. Each year, speakers share hands-on experience dealing with current challenges as well as successes in medical information departments. Participants are encouraged to take part in the interactive workshop sessions and discussions happening throughout the conference. This conference is the one and only European forum dedicated to medical information and communications, making it the premier opportunity to network, exchange learnings, and share best practices.

Key Topics

  • Moving from traditional phone- and email-based channels to innovative digital channels to disseminate medical information
  • Examples of successes in digital presented by the most advanced players
  • Comparison between pharmaceuticals and medical devices - can the same strategies be used, or is a different approach needed?
  • Regulatory and legal issues: developments since the rejection of Safe Harbor - what's the impact of the new data privacy rules in Europe (Data privacy shield)
  • How to optimise collaboration between MSL and MedInfo roles
  • Effects of globalisation on different roles? How much localisation and how much globalisation is suitable?

Join the Annual European Medical Information and Communications Conference and find answers to issues of daily importance:

  • Are you clear on how to handle questions about off-label use?
  • Do you understand the latest changes in data privacy regulations?
  • Do you know the pros and cons of outsourcing medical information services?
  • How do you ensure high quality when you outsource customer service? Are you not happy with the quality of your outsourced customer services?
  • Is quality an issue in your outsourced medical information function?
  • Is your medical information website getting high enough usage? Learn how to improve hits and increase the number of users.
  • You have develop a website for customer service - now how do you get people to use your site? Is all your effort of building the site going to waste because nobody uses it?
  • How can you be successful in globalising medical information? From a local perspective, how can you best adapt and implement global guidelines?

Call for Poster Abstracts
Become an active part of the conference you attend by presenting a poster. Submit an abstract and take this opportunity to present your research and work to your peers at the conference. It's the perfect place for you to put your research into the limelight, to create discussions around your results with other professionals or to generate interest around a subject you feel needs more attention.

The European Medical Information and Communication Conference stretches across a variety of topics that you have encountered during your work. Contribute to the discussions at the conference by sharing your own experience. Please only submit abstracts matching the following topics:

  • From Safe Harbor to The EU/US Privacy Shield - What do you Need to Know in Medical Information?
  • The Future of Medical Information - Changing Modes of Communication
  • Globalization/Regionalization - Is it Possible to Have one Framework?
  • Medical Information and Medical Scientific Liaisons (MSLs) Partnerships
  • Providing Medical Information for Medical Devices
  • When Medical Information Goes On-line - Optimising the Sharing Experience
  • Considerations, User-Interface and Other Considerations
  • Supporting Established Products in Medical Information
  • Outsourcing and Insourcing Medical Information
  • Medical Information for Challenging Geographies

Deadline: Submit Poster Abstracts by Monday, 26 September 2016.

For further information, please visit:
http://www.diaglobal.org/en/conference-listing/meetings/2016/11/10th-annual-european-medical-information-and-communications-conference-and-exhibition

About DIA
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.

DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, the Middle East, and Africa (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan).

Most Popular Now

Regorafenib to be tested in brain cancer patients …

Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in the US ...

Sanofi and Google to develop new healthcare Innova…

Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping i...

Bristol-Myers Squibb provides update on pending me…

Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation (NASDAQ: ...

Japan becomes the first country to approve Roche's…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of a...

Breztri Aerosphere (PT010) approved in Japan for p…

AstraZeneca announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy...

FDA approves Amgen and Allergan's KANJINTITM (tras…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTITM (trastuzumab-anns) for all approved ind...

Vitamin D may not help your heart

While previous research has suggested a link between low levels of vitamin D in the blood and an increased risk of cardiovascular disease, a new Michigan State University...

Human-on-a-chip model tests cancer drug efficacy a…

A reconfigurable "body-on-a-chip" model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organ...

Pathogen engineered to self-destruct underlies can…

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-dest...

Artificial DNA can control release of active ingre…

A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was o...

How gastric stem cells fight bacteria

Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by re...

Researchers identify enzyme that suppresses immune…

Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing. In breast cancer especially, only a ...